TP53AIP1 (tumor protein p53 regulated apoptosis inducing protein 1) is a p53-regulated pro-apoptotic gene that functions as a key mediator of p53-dependent cell death in response to DNA damage 1. The protein localizes to the mitochondrial matrix and plays a critical role in apoptosis initiation 2. In breast cancer, TP53AIP1 suppresses tumor growth and cell proliferation by inducing autophagy through inhibition of the AKT/mTOR signaling pathway; low TP53AIP1 expression correlates with reduced patient survival 3. Constitutionally truncating TP53AIP1 mutations increase susceptibility to cutaneous melanoma (OR=3.3), with mutations showing reduced mRNA expression during melanoma progression 1. TP53AIP1 has been identified as a prognostically relevant gene in multiple cancer contexts, including breast cancer risk stratification models based on apoptosis-related and mitochondria-related gene signatures 45. Additionally, TP53AIP1 variants have been associated with alexithymia, suggesting broader neurobiological functions beyond cancer pathways 6. Clinical significance includes potential therapeutic targeting through TP53AIP1 restoration to overcome drug resistance and enhance apoptosis in cancer treatment 23.